Lieu Hsiao
Insider CIK 1468482 · NLTX Executive VP, Clinical Dev. · NGM SVP, Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 100,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 150,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 150,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 159,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 25,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 190,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 39,750 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | U Tender | 2024-04-05 | 2024-04-08 | 19,349 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | F Tax w/h | 2024-01-16 | 2024-01-18 | 5,430 | $1.34 | $7.3K | 54,254 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-11-06 | 2023-11-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-11-06 | 2023-11-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2023-11-06 | 2023-11-08 | 150,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-11-06 | 2023-11-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2023-11-06 | 2023-11-08 | 100,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2023-11-06 | 2023-11-08 | 150,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2023-11-06 | 2023-11-08 | 25,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-11-06 | 2023-11-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2023-11-06 | 2023-11-08 | 190,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-11-06 | 2023-11-08 | 190,000 | — | $0 | 190,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-03-02 | 2023-03-06 | 159,000 | — | $0 | 159,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award | 2023-03-02 | 2023-03-06 | 53,000 | — | $0 | 55,605 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2022-11-04 | 2022-11-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2022-03-03 | 2022-03-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2021-10-05 | 2021-10-07 | 2,000 | — | $0 | 190,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-10-05 | 2021-10-07 | 2,000 | $22.00 | $44.0K | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2021-10-05 | 2021-10-07 | 2,000 | $12.06 | $24.1K | 2,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2021-08-12 | 2021-08-13 | 8,000 | — | $0 | 192,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2021-08-12 | 2021-08-13 | 8,000 | $12.06 | $96.5K | 8,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-08-12 | 2021-08-13 | 8,000 | $23.50 | $188.0K | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-08-11 | 2021-08-13 | 2,258 | $23.00 | $51.9K | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2021-03-17 | 2021-03-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2020-05-15 | 2020-05-18 | 1,562 | $22.00 | $34.4K | 182 | SEC↗ |
| NLTX Nile Therapeutics, Inc. | P Buy deriv | 2012-03-30 | 2012-04-02 | 9,375 | — | $0 | 9,375 | SEC↗ |
| NLTX Nile Therapeutics, Inc. | P Buy | 2012-03-30 | 2012-04-02 | 12,500 | — | $0 | 12,600 | SEC↗ |